Variation in Cost of Actinic Keratosis Management

Share this content:
Variation in Cost of Actinic Keratosis Management
Variation in Cost of Actinic Keratosis Management

THURSDAY, March 2, 2017 (HealthDay News) -- There is considerable variation in the cost of actinic keratosis (AK) management, according to a study published online March 1 in JAMA Dermatology.

Joslyn S. Kirby, M.D., from the Penn State Milton S. Hershey Medical Center, and colleagues conducted a retrospective cohort study using data from the MarketScan medical claims database of 488,324 continuously enrolled members with two or more claims for AK.

The researchers found that there were 1,085,985 claims related to AK, with dermatologists accounting for 71.0 percent of claims. The total two-year cost was $111.5 million: $52.4 million and $59.1 million in 2011 and 2012, respectively. There was variation in the unadjusted ratio of mean cost in the highest quintile versus the lowest quintile (Q5:Q1) from 9.49 to 15.10. After adjustment, the ratios varied from 1.72 to 1.80.

"There is variation in AK management cost within and between regions. This is not fully explained by differences in patient characteristics such as age, sex, or comorbidities," the authors write. "The annual cost for 10 common conditions from Medicare had lower Q5:Q1 ratios that ranged from 1.33 (joint degeneration of back/neck) to 1.69 (chronic sinusitis) when compared with 1.72 to 1.80 for AKs."

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Mortality Risks of Exclusive Cigar, Cigarette, Pipe Use ID'd

Mortality Risks of Exclusive Cigar, Cigarette, Pipe Use ...

Higher risk of tobacco-related cancer death for current/former cigarette, current cigar, pipe smoking

Burnout Found Prevalent Among Doctors in Single Health System

Burnout Found Prevalent Among Doctors in Single Health ...

Link between patient satisfaction and emotional exhaustion; also tied to odds of leaving organization

Ulipristal Achieves Amenorrhea for Symptomatic Leiomyomas

Ulipristal Achieves Amenorrhea for Symptomatic Leiomyomas

Ulipristal superior to placebo to achieve amenorrhea for bleeding due to symptomatic uterine leiomyomas

is free, fast, and customized just for you!

Already a member?

Sign In Now »